Moreover, Li et al. found that the lower expression level of miR-23b is associated with worse prognosis of ovarian cancer patients, and miR-23b-induced repression of RUNX2 slow downs ovarian cancer cell proliferation [167]. The gene discussed is RUNX2; the disease is ovarian carcinoma.